Surface Oncology
(NASDAQ) SURF
Surface Oncology Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$30.00M
Net Income (TTM)
$94.01M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
SURF News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Surface Oncology
Industry
Biotechnology
Sector
Health CareEmployees
60
CEO
Robert W. Ross, MD
Website
www.surfaceoncology.comHeadquarters
Cambridge, MA 02139, US
SURF Financials
Key Financial Metrics (TTM)
Gross Margin
100%
Operating Margin
-2%
Net Income Margin
-2%
Return on Equity
-62%
Return on Capital
-43%
Return on Assets
-41%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$30.00M
Operating Income
$61.87M
EBITDA
$61.87M
Operating Cash Flow
$59.55M
Capital Expenditure
$497.00K
Free Cash Flow
$60.05M
Cash & ST Invst.
$124.82M
Total Debt
$56.04M
Surface Oncology Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
35
N/A
Net Income
$28.19M
-9.3%
EBITDA
$23.09M
+4.3%
Quarterly Fundamentals
Net Cash
$46.77M
-53.0%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
-100.0%
Short Term Debt
$9.49M
+11.4%
Return on Assets
-40.84%
N/A
Return on Invested Capital
-43.07%
N/A
Free Cash Flow
$19.54M
-535.9%
Operating Cash Flow
$19.56M
-525.7%